Advertisement

Topics

Icon Polymer Group Ltd Company Profile

05:27 EDT 22nd June 2018 | BioPortfolio

The Icon Polymer Group is a world class global provider of technically complex and innovative elastomer solutions across a broad spectrum of industries requiring a versatile, viable and market-centred approach to meeting the elastomer need

Location

Retford
Nottinghamshire
DN22 6HH
United Kingdom

Contact

Phone: 44 (0) 1777 714 300
Fax: 44 (0) 1777 709 739


News Articles [760 Associated News Articles listed on BioPortfolio]

ICON and DuPage Medical Group announce clinical research partnership

ICON plc, a global provider of drug development and commercialization solutions and services, today announced that PMG Research, Inc., part of ICON Site and Patient Recruitment, and DuPage Medical Gro...

Icon’s PMG Research partners with IL-based medical group

Icon has announced a clinical research partnership with DuPage Medical Group, a Chicago, IL-based network with more than 700 physicians across more than 100 locations.

BancorpSouth Bank To Acquire Icon Capital Corporation In Houston, Texas

Icon operates seven (7) full-service banking offices in the Houston, Texasmetropolitan area.  As of March 31, 2018(unaudited), Icon, on a consolidated basis, reported Read more...

Recent Research Analysts' Ratings Updates for Icon

Several brokerages have updated their recommendations and price targets on shares of Icon in the last few weeks: 1/24/2018 - Icon was given a new $109.00 price target on by analysts at Mizuho. They no...

ClinicalRM becomes ICON GPHS to rapidly respond to global health crises, says CRO

ClinicalRM â which ICON acquired in 2016 â has become ICON Government and Public Health Solutions (GPHS), providing full-service clinical trial execution and functional services to government, NGOs,...

pSivida acquires Icon, rebrands as EyePoint Pharmaceuticals

pSivida Corp. has acquired the specialty biopharmaceutical company Icon Bioscience Inc. and will rebrand as EyePoint Pharmaceuticals, according to pSivida CEO Nancy Lurker, who spoke with Healio.com/O...

ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase ...

ICON Media ContactOlivia PimentaWeber Shandwick44-207 067 0557OPimenta@webershandwick.com Read more...

Join Mapi Group & ICON plc for a November 6th Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access Workshop (Glasgow, Scotland)

Please join Mapi Group and ICON plc for an Early Integrated Scientific Advice in Product Development: Get Real and Adapt to Accelerate Patient Access Workshop in Glasgow, Scotland on November 6th. Dur...

Drugs and Medications [197 Associated Drugs and Medications listed on BioPortfolio]

Bacitracin zinc and polymyxin b sulfate [Bausch & Lomb Incorporated]

Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment USP (Sterile)

Tropicamide [Bausch & Lomb Incorporated]

Tropicamide Ophthalmic Solution USP (Sterile)

Quik gel [Cinogen Cosmetics Zhaoqing, LTD.]

Quik Gel Advanced Hand Sanitizing Gel

Erythromycin [Bausch & Lomb Incorporated]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Murocel [Bausch & Lomb Incorporated]

Drug Facts

PubMed Articles [2544 Associated PubMed Articles listed on BioPortfolio]

Translation and validation study of the Chinese version of the Iconographical Falls Efficacy Scale-Short Version (Icon-FES).

The 30-item Iconographical Falls Efficacy Scale (Icon-FES) is the first instrument developed to assess older people's concern about falling using pictures. The short version of Icon-FES (10-item Icon-...

A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD.

This phase 1 study evaluated the safety and tolerability of single intravitreous injections (IVIs) of ICON-1 (Iconic Therapeutics, South San Francisco, CA) in patients with neovascular age-related mac...

Icon arrays help younger children's proportional reasoning.

We investigated the effects of two context variables, presentation format (icon arrays or numerical frequencies) and time limitation (limited or unlimited time), on the proportional reasoning abilitie...

Randomized Cross-over Comparison of Icon™ Reusable Underwear to Disposable Pads for the Management of Mild to Moderate Urinary Incontinence.

The objective of this study was to compare disposable pads to Icon™ reusable underwear for the management of urinary incontinence on dimensions of quality of life and product performance.

Electrical velocimetry for non-invasive monitoring of the closure of the ductus arteriosus in preterm infants.

Closure of a patent ductus arteriosus (PDA) in preterm infants modifies cardiac output and induces adaptive changes in the hemodynamic situation. The present study aims to analyze those changes, throu...

Clinical Trials [3804 Associated Clinical Trials listed on BioPortfolio]

The Effect of ICON Treatment on WPL With Patients After Fixed Orthodontic Appliances

The aim of this study is to determine the effect of ICON on White spot lesions compared to CPP-ACPF plus.

Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate the safety and effects of repeated intravitreal injections of ICON-1 0.6 mg administered as maintenance therapy or in combination with aflibercept ...

Randomized Controlled Crossover Comparison of Icon Underwear to Disposable Pads

This is a randomized cross over trial to compare quality of life and product performance between Icon reusable underwear versus standard disposable pad in patients with mild to moderate ur...

Non-invasive Monitor in Endoscopic Invasive Procedure

We include the patients who need painless invasive endoscopic precedure, we collect the dempgraphic data and apply the non-invasive device ICON on patients during the who procedure.

Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation

The aim of the study is to investigate the use of a new FDA-approved non-invasive bio-impedance cardiac monitor, ICON, to detect hemodynamic effects during sedation in children undergoing ...

Companies [1796 Associated Companies listed on BioPortfolio]

Icon Polymer Group Ltd

The Icon Polymer Group is a world class global provider of technically complex and innovative elastomer solutions across a broad spectrum of industries requiring a versatile, viable and market-centred...

ICON Clinical Research

ICON was founded in 1990 by a group of experienced professionals, who were dedicated to providing the pharmaceutical and biotechnology industries with exceptional clinical research and biometric servi...

ICON Eyecare

ICON Eyecare is a leading surgical and medical eye care provider, based out of Denver, CO. Since 1999, ICON has been building a Center of Ophthalmology Excellence empowered by an ...

ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic devel...

ICON plc.

ICON plc. is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic deve...

More Information about "Icon Polymer Group Ltd" on BioPortfolio

We have published hundreds of Icon Polymer Group Ltd news stories on BioPortfolio along with dozens of Icon Polymer Group Ltd Clinical Trials and PubMed Articles about Icon Polymer Group Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Icon Polymer Group Ltd Companies in our database. You can also find out about relevant Icon Polymer Group Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record